It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The glucagon-like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in glucose homeostasis and food intake. GLP1R agonists (GLP1RA) are widely used in the treatment of diabetes and obesity, yet visualizing the endogenous localization, organization and dynamics of a GPCR has so far remained out of reach. In the present study, we generate mice harboring an enzyme self-label genome-edited into the endogenous Glp1r locus. We also rationally design and test various fluorescent dyes, spanning cyan to far-red wavelengths, for labeling performance in tissue. By combining these technologies, we show that endogenous GLP1R can be specifically and sensitively detected in primary tissue using multiple colors. Longitudinal analysis of GLP1R dynamics reveals heterogeneous recruitment of neighboring cell subpopulations into signaling and trafficking, with differences observed between GLP1RA classes and dual agonists. At the nanoscopic level, GLP1Rs are found to possess higher organization, undergoing GLP1RA-dependent membrane diffusion. Together, these results show the utility of enzyme self-labels for visualization and interrogation of endogenous proteins, and provide insight into the biology of a class B GPCR in primary cells and tissue.
Visualizing endogenous GPCRs is challenging. Here the authors generate mice with an enzyme self-label genome-edited into the endogenous glucagon-like peptide-1 receptor locus, design fluorescent dyes for specific labelling in complex tissue, and reveal tissue-level organisation and dynamics of an endogenous class B GPCR.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of Birmingham, Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
2 University of Birmingham, Institute for Immunology and Immunotherapy, and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
3 University of Birmingham, Genome Editing Facility, Technology Hub, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
4 University of Birmingham, National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Birmingham, Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
5 Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany (GRID:grid.418832.4) (ISNI:0000 0001 0610 524X)
6 University of Birmingham, Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)